Your Biopharmaceutical Development and Manufacturing Partner

Nanotherapeutics, Inc. Appoints Mento A. "Chuck" Soponis Chairman and CEO - January 2006

Nanotherapeutics, Inc., a privately held corporation focused on the development and application of proprietary drug delivery systems, announced today the appointment of Mento A. "Chuck" Soponis as Chairman and CEO to lead the company into its next phase of growth. Company also announces: New U.S. Patent Issued, $5.6 Million in Funding from the U.S. Navy and... 

Full Article

Copyright 2017 NANOTHERAPEUTICS, INC.  All rights reserved.